-
Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?Wehner GJ, Jing L, Haggerty CM et al. -
Routine Continuous Electrocardiographic Monitoring Following Percutaneous Coronary InterventionsMA Al-Hijji , R Gulati，M Singh et al.
-
Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trialM Mancone, R Cavalcante, PW Serruys et al.
-
Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic StudyD Pellegrini, R Kawakami, G Guagliumi et al.
-
Treatment of higher-risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary interventionAJ Kirtane, D Doshi, MB Leon et al.
-
Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol : A meta-analysis of trials with East Asian populationsZhang L, Zhang S, Ge J et al.
-
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart FailureYancy CW, Jessup M, Bozkurt B et al.
-
2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary PlaquesMHwa Yamamoto, A Maehara, GW Stone et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
